BSE filing, NSE: HISARSP. Summary written from the filing by ALFA Finder's alert engine.
Hisar Spinning Mills Ltd: key numbers
- Share price
- ₹50.83
- Market cap
- ₹18.99 Cr
- Revenue (annual)
- ₹44.11 Cr
- Net profit (annual)
- ₹3.31 Cr
- P/E (TTM)
- 5.5×Sector 49.5×
- Promoter holding
- 50.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hisar Spinning Mills Ltd
All →Hisar Spinning Mills Other Announcement
Hisar Spinning Mills filed a nil monthly report on physical share re-lodgement for September 2026 as mandated by SEBI. No transfer requests were received, processed, or rejected during the period.
Hisar Spinning Mills Annual General Meeting
Hisar Spinning Mills Limited held its 34th Annual General Meeting on September 30, 2026. Shareholders considered the adoption of financial statements and approved remuneration increases for key personnel.
Hisar Spinning Mills Annual Report
Hisar Spinning Mills filed its 34th Annual Report for FY 2025-26 with BSE under Reg 34(1). The filing also carries the AGM notice for September 30, 2026.
Hisar Spinning Mills Annual General Meeting
Hisar Spinning Mills Ltd scheduled its 34th Annual General Meeting for September 30, 2026. Key agenda items include adopting financial statements and increasing remuneration for the CEO and WTD.
Hisar Spinning Mills Q1 FY27 Results: Net Profit ₹1.1 Cr, Up 22.2% YoY
Hisar Spinning Mills Ltd reported revenue from operations of ₹12.3 Cr (+11.8% YoY) and net profit of ₹1.1 Cr (+22.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · +22.2% YoY
Hisar Spinning Mills Board Meeting Date
Hisar Spinning Mills Ltd scheduled a board meeting for August 14, 2026. The board will consider and approve unaudited financial results for the June 2026 quarter.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.